A Clinical Study of CAR-T Cells in the Treatment of Relapsed and Refractory Hematological Malignancies

NCT04008524 · clinicaltrials.gov ↗
AVAILABLE
Status
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Institute of Hematology & Blood Diseases Hospital, China

Collaborators